MedTrace Logo

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

NCT04579822 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300000

Last updated 2020-10-08

No results posted yet for this study

Summary

This is a nationwide cohort study to assess maternal and fetal outcomes following vaccination with a quadrivalent influenza vaccine (QIV) during pregnancy.

Conditions

  • Pregnancy Related
  • Influenza Virus Vaccine Adverse Reaction

Interventions

BIOLOGICAL

influenza vaccine

quadrivalent influenza vaccination in the flu seasons

Sponsors & Collaborators

  • Government-wide R&D Fund project for infectious disease research (GFID)

    collaborator UNKNOWN

  • Sungkyunkwan University

    lead OTHER

Principal Investigators

  • Ju-Young Shin, PhD · Sungkyunkwan University

Eligibility

Min Age
20 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-10-31
Completion
2022-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579822 on ClinicalTrials.gov